BDMD
Price
$0.09Alerts
Change
-$0.01 (-10.00%)
Updated
Nov 20 closing price
Capitalization
2.82M
Intraday BUY SELL Signals
ECOR
Price
$4.42Alerts
Change
-$0.43 (-8.87%)
Updated
Nov 20 closing price
Capitalization
65.37M
110 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDMD vs ECOR

BDMD vs ECOR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BDMD vs. ECOR commentary
Nov 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDMD is a Hold and ECOR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BDMD with price predictions
Nov 20, 2026

BDMD in upward trend: price may jump up because it broke its lower Bollinger Band on October 19, 2026

BDMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 25 of 31 cases where BDMD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BDMD's RSI Oscillator exited the oversold zone, 19 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.

The Momentum Indicator moved above the 0 level on November 20, 2026. You may want to consider a long position or call options on BDMD as a result. In 32 of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 44%.

The Moving Average Convergence Divergence (MACD) for BDMD just turned positive on November 11, 2026. Looking at past instances where BDMD's MACD turned positive, the stock continued to rise in 20 of 46 cases over the following month. The odds of a continued upward trend are 43%.

Following a +10.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where BDMD advanced for three days, in 70 of 120 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

The Aroon Indicator for BDMD entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.081) is normal, around the industry mean (4.142). P/E Ratio (-0.159) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.371) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. BDMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for ECOR with price predictions
Nov 20, 2026

ECOR sees MACD Histogram just turned negative

ECOR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 12, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 40 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ECOR as a result. In 76 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECOR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for ECOR entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +21.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where ECOR advanced for three days, in 240 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

ECOR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ECOR's P/B Ratio (-23.428) is slightly lower than the industry average of (4.142). P/E Ratio (-4.394) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (2.571) is also within normal values, averaging (40.124).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. ECOR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ECOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ECOR: Fundamental Ratings
ECOR
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDMDECOR
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
44%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
43%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 10 days ago
58%
Bullish Trend 17 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
COMPARISON
Comparison
Nov 21, 2026
Stock price -- (BDMD: $0.09 vs. ECOR: $4.42)
Brand notoriety: BDMD and ECOR are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BDMD: 14% vs. ECOR: 434%
Market capitalization -- BDMD: $2.82M vs. ECOR: $65.37M
BDMD [@Medical/Nursing Services] is valued at $2.82M. ECOR’s [@Medical/Nursing Services] market capitalization is $65.37M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDMD’s FA Score shows that 0 FA rating(s) are green while ECOR’s FA Score has 1 green FA rating(s).

  • BDMD’s FA Score: 0 green, 5 red.
  • ECOR’s FA Score: 1 green, 4 red.
According to our system of comparison, both BDMD and ECOR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDMD’s TA Score shows that 5 TA indicator(s) are bullish while ECOR’s TA Score has 4 bullish TA indicator(s).

  • BDMD’s TA Score: 5 bullish, 2 bearish.
  • ECOR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BDMD is a better buy in the short-term than ECOR.

Price Growth

BDMD (@Medical/Nursing Services) experienced а -0.88% price change this week, while ECOR (@Medical/Nursing Services) price change was -15.81% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -11.44%. For the same industry, the average monthly price growth was -15.18%, and the average quarterly price growth was -18.29%.

Reported Earning Dates

ECOR is expected to report earnings on Mar 11, 2027.

Industries' Descriptions

@Medical/Nursing Services (-11.44% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

BDMD and

Correlation & Price change

A.I.dvisor tells us that BDMD and IRTC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDMD and IRTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDMD
1D Price
Change %
BDMD100%
-12.91%
IRTC - BDMD
27%
Poorly correlated
+0.51%
INFU - BDMD
22%
Poorly correlated
+2.06%
ECOR - BDMD
21%
Poorly correlated
-8.87%
CERS - BDMD
21%
Poorly correlated
-2.63%
LFWD - BDMD
20%
Poorly correlated
-5.46%
More

ECOR and

Correlation & Price change

A.I.dvisor tells us that ECOR and QDEL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ECOR and QDEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ECOR
1D Price
Change %
ECOR100%
-8.87%
QDEL - ECOR
29%
Poorly correlated
-6.73%
SENS - ECOR
29%
Poorly correlated
-9.94%
BWAY - ECOR
28%
Poorly correlated
-2.86%
PFSA - ECOR
28%
Poorly correlated
-6.40%
STIM - ECOR
26%
Poorly correlated
+0.81%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LTC42.240.10
+0.24%
LTC Properties
APAC10.30N/A
N/A
StoneBridge Acquisition II Corp
OIS7.39-0.26
-3.40%
OIL States International
STLA3.34-0.20
-5.65%
Stellantis NV
RMSG0.13-0.03
-17.38%
Real Messenger Corporation